4.1 Potential Origin-tracing Markers of CM-sEVs Since myocardial tissue cannot be directly obtained from patients, identifying bioactive molecules in the blood that reflect pathological changes in cardiomyocytes is highly significant for the early prediction, diagnosis, and prognosis of CVDs and their associated complications.
← all excerpts
The Origin and Application of Cardiomyocyte-Derived Small Extracellular Vesicles: A Systematic Review.
1
—
—